Introduction
Nickel (Ni) is a non-essential metal of great environmental concern because it is widely used in industrial and medical processes. Epidemiological and experimental studies have shown an increased incidence of lung and nasal cancers associated with chronic exposure to Ni compounds (1, 2) . Due to its weak mutagenesis, epigenetic changes have been implicated in Ni carcinogenesis (3, 4) . Recently, accumulating evidence revealed that DNA methylation and histone modifications are involved in Ni compoundinduced gene modification at specific loci (5-7), such as p16, serpin, O6-methylguanine DNA methyltransferase (MGMT), transgenic gpt and others, supporting the notion that epigenetic changes contribute to Ni compound-induced cellular toxicity and tumorigenicity. However, few studies show that microRNAs (miRNAs), as an important epigenetic factor, are involved in Ni-induced carcinogenesis.
miRNAs are endogenous, small, non-coding RNAs of 19-22 nucleotides, which repress gene expression in a variety of eukaryotic organisms. These single-stranded RNAs interact with specific target messenger RNAs (mRNAs) through an almost perfect complementarity with sequences located in the 3′ untranslated region (3′-UTR), where they induce mRNA degradation or translational inhibition (8, 9) . miRNAs are considered to play crucial roles in many normal cellular processes and the multistep processes of carcinogenesis (10) (11) (12) . It is now widely accepted that miRNAs undergo the same regulatory mechanisms as any other protein-coding gene including epigenetic regulation (13, 14) . DNA methylation is an important epigenetic modification that is involved in gene regulation. Several lines of evidences identified the presence of CpG island methylation-associated silencing of miRNA with tumor suppressor features in human cancer (15) (16) (17) , such as miR-1, miR-129, miR-34b and miR-148a. Thus, aberrant hypermethylation events in the regulatory regions of miRNAs might also play a role in cancer development. Intriguingly, some miRNAs target, directly or indirectly, effectors of the epigenetic machinery such as DNMTs, HDACs and polycomb genes (18) (19) (20) , suggesting miRNAs can also indirectly regulate gene expression by directly regulating epigenetic processes. However, to our knowledge, a direct crosstalk between miRNAs and DNMTs has never been reported.
Previously, we established a model of human bronchial epithelial (16HBE) cell transformation induced by nickel sulfide (NiS) (21) . The epigenetic silencing of the MGMT gene locus and upregulation of DNA methyltransferase 1 (DNMT1) expression were specifically detected in NiS-transformed cells (5) . Given the facts that some miRNAs can regulate DNA methylation by targeting DNMTs (22, 23) , we hypothesized some miRNAs targeting DNMT1 in silico predictions are aberrantly expressed in NiS-transformed cells, leading to upregulation of DNMT1. In turn, DNMT1 decrease miRNAs expression via promoter hypermethylation.
To test this hypothesis, we first examined the expression of a group of miRNAs, which have sequence complementarity to the 3′-UTR of DNMT1, namely miR-148a, miR-148b and miR-152 in NiStransformed and vehicle-treated cells. We found that the expression of miR-152 was significantly downregulated in NiS-transformed cells as compared with control cells. To determine a reciprocal link between miR-152 and DNMT1 in NiS-transformed cells, we investigated the function of miR-152 in DNA methylation and the epigenetic effect of DNMT1 on miR-152. Here, our results show that a functional crosstalk between miR-152 and DNMT1 via a double-negative feedback loop is involved in NiS-induced transformation.
The crosstalk between miR-152 and DNMT1 in cancer medium supplemented with 10% fetal bovine serum and 2 mM l-glutamine. Cells were treated with crystalline NiS at 1.0 or 2.0 µg/cm 2 for 24 h. The cultures were split 1:4 and subjected to another round of treatment. The cells were treated with NiS for one, two or three times. NiS-transformed cell lines (NSTC1 and NSTC2), stable shDNMT1-expressing cell lines (NSTC2shDNMT1) and stable Green Fluorescent Protein (GFP) control cells (NSTC2shGFP) were generated as described previously (5) . HEK293T human embryonic kidney cells were obtained from American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. DAC treatment was given at 3 µM for 72 h. Transfections were performed with a Lipofectamine 2000 Kit (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Double-stranded miR-152 mimics, singlestranded miR-152 inhibitor or their relative negative control RNAs (RiboBio, Guangzhou, China) at a final concentration of 50 nM were introduced into cells.
Cell proliferation About 1 × 10
4 cells were plated in triplicate and harvested at the indicated time points. The number of viable cells was determined using a Z2 Particle Count and Size Analyzer (Beckman-Coulter, Miami, FL). Triplicate plates were counted for each cell lines.
Colony formation assay
Cells were seeded onto six-well plates at 400 cells per well. Two weeks later, colonies were fixed with 100% methanol for 15 min and stained with 0.1% crystal violet for 20 min. Colonies with diameter >1.5 mm were counted.
Construction of vectors
The 3′-UTRs of DNMT1 containing an intact miR-152 recognition sequence was amplified by PCR from genomic DNA, and the PCR product were subcloned into a psiCHECK™-2 Vector (Promega, Madison, WI). A psiCHECK™-2 construct containing the DNMT1 3′-UTR with mutations in the seed sequence was synthesized with a QuikChange Site-Directed Mutagenesis Kit (Stratagene; Agilent Technologies, Palo Alto, CA). The promoter region of miR-152 was amplified by PCR from genomic DNA, and the PCR product was subcloned into pGL3-basic vector (Promega). All primers used are shown in (Supplementary Table 1 , available at Carcinogenesis Online). All constructs were confirmed by sequencing.
Quantitation of gene expression by quantitative real-time PCR
Total RNA containing miRNA was extracted using the miRNeasy Mini Kit (Qiagen, Hilden, Germany). Target miRNA was reverse transcribed to complementary DNA by a gene-specific RT primer using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). TaqMan MicroRNA Assay was performed with Premix Ex Taq (Takara, Shiga, Japan) using the Thermal Cycler Dice Real-Time System (Takara). The relative quantification value of the target, normalized to the control, was calculated by the comparative Ct methods. U6 RNA was used as an internal control. To determine the DNMT1 mRNA levels, real-time PCR was performed by using a standard SYBR® Green PCR Kit (Takara) protocol. Gene expression values were calculated based on the comparative quantitative method (the ΔΔC T method) and normalized to the values of β-actin. Samples were analyzed in triplicate. The primers used are shown in Table I .
Immunoblotting
Cells were lysed in lysis buffer containing 1% NP-40, 1% sodium dodecyl sulfate, 0.5% sodium deoxycholate, 10 µg/ml phenylmethylsulfonyl fluoride, 0.2 mM ethylenediaminetetraacetic acid and 0.5 mM dithiothreitol. Cell lysates were centrifuged at 13 000g for 15 min at 4°C, and insoluble debris was discarded. Soluble proteins (20 µg) were subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Immunoblottings were performed with 1:1000 diluted anti-glyceraldehyde 3-phosphate dehydrogenase (no. sc-166545) (Santa Cruz Biotech, Santa Cruz, CA) and 1:1000 diluted anti-DNMT1 (D4692) (Sigma-Aldrich).
Luciferase reporter assay
The cells were transiently transfected with 0.5 µg of reporter plasmids alone or cotransfected with or without miRNA mimics or inhibitors using Lipofectamine 2000 according to the protocol (Invitrogen). The activities of reporter genes with renilla luciferase and the internal standard firefly luciferase were quantified by a Dual-Luciferase Reporter Assay System (Promega). Independent triplicate experiments were done for each plasmid construct. (18) and PubMed. About 0.5 µg genomic DNA was treated with sodium bisulfite and subjected to PCR, using primer sets designed to amplify regions of interest (Supplementary Table 1 , available at Carcinogenesis Online). The bisulfite-sequencing analysis was carried out as described previously (5) .
Methylation analysis

Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assay was performed using EZ ChIP Assay Kit (Upstate Biotechnology) with minor modifications. Briefly, protein extract from 1 × 10 6 cells was cross-linked to DNA by addition of formaldehyde directly to the culture medium to a final concentration of 1% for 10 min at room temperature. The cross-linking reaction was quenched by adding glycine solution to a final concentration of 0.125 M for 5 min at room temperature. The medium was then removed, and cells were collected and suspended in sodium dodecyl sulfate lysis buffer containing 1× protease inhibitor cocktail (Upstate Biotechnology). Cells were sonicated to yield fragments of 500-bp average size. The sonicated samples were precleared with 60 µl of salmon sperm DNA/ protein G agarose beads for 1 h at 4°C with agitation. The soluble chromatin fraction was collected, and 1% of the supernatant was applied for input normalization. Five microliter of either normal mouse IgG (no.12-371B) (the negative control), anti-RNA polymerase II (no.05-623B) (the positive control) (Upstate Biotechnology), anti-MeCP2 (no.ab3752) (Abcam, Cambridge, MA) or anti-DNMT1 (no.IMG-261A) (Imgenex, San diego, CA) was added and incubated overnight with rotation. Immune complexes were collected with 60 µl of salmon sperm DNA/protein G agarose beads. After washing and elution, the cross-links were reversed, and the samples were digested with proteinase K for 2 h at 45°C. DNA was recovered and purified using spin columns (Mo Bio Laboratories, Carlsbad, CA).
Quantitative PCR analysis of immunoprecipitated DNA
To allow accurate measurement of the amount of DNA precipitated, quantitative PCR was performed using a SYBR® Green QPCR Kit (Takara). A fragment of miR-152 promoter was amplified by primer (Supplementary Table 1 , available at Carcinogenesis Online). The relative differences among cells were determined using the ΔΔC T method. A ΔC T value was calculated for each sample using the C T values for the input DNA samples to normalize the ChIP assay results. A ΔΔC T value was then calculated by subtracting the ΔC T for the control cells from each treatment ΔC T within an experiment. The ΔΔC T values were converted to fold differences compared with the control by raising 2 to the ΔΔC T power.
Statistical analysis
All quantified data represent an average of at least triplicate samples or as indicated. Error bars represent standard deviation of the mean. Statistical significance was determined by the Student's t-test, and 2-tailed P values <0.05 were considered significant.
Results
miR-152 is downregulated in NiS-treated and transformed human cells
Previously, we identified upregulation of DNMT1 expression in NiS-treated and transformed human cells (5) . Using computer-aided algorithms, TargetScan, miRanda and PicTar, in NiS-transformed cells and vehicle-treated cells, we predicted a group of miRNAs that have sequence complementarity to the 3′-UTR of DNMT1, namely miR148a, miR-148b and miR-152. To determine whether these miRNAs are involved in downregulation of DNMT1, we first compared the expression of miR-148a, miR-148b and miR-152 between NiStransformed cells and control cells treated with vehicle alone using TapMan real-time PCR. We found that the expression of miR-152, but not miR-148a and miR-148b, was significantly downregulated in NiStransformed cells NSTC1 and NSTC2, compared with control cells ( Figure 1A) . In order to define whether the suppression of miR-152 expression occurred at an early stage of tumorigenesis, we detected miR-152 expression in cells treated with NiS at doses of 0.5, 1.0 and 2.0 µg/cm 2 for 24 h administered one, two or three times every 2 days, respectively. No significant changes were observed in cells treated with NiS one or two times. However, significant dose-dependent downregulation of miR-152 expression was found in cells treated with NiS three times ( Figure 1B) , suggesting that downregulation of miR-152 may be an early event involved in NiS-induced cell transformation.
miR-152 represses DNMT1 expression by targeting 3′-UTR
To test whether miR-152 downregulates the expression of DNMT1, we first transfected miR-152 mimics and negative control into NiStransformed cells NSTC1 and NSTC2, and then detected DNMT1 expression at mRNA and protein level. The results showed expression levels of miR-152 were remarkably increased in NiS-transformed cells transfected with this double-stranded RNA (dsRNA) as compared with that in control-transfected NiS-transformed cells (Figure 2A) . Moreover, transfection of miR-152 resulted in significant decrease of DNMT1 expression at both mRNA and protein levels ( Figure 2B and 2C), indicating miR-152 is involved in both DNMT1 mRNA degradation and post-transcriptional regulation. As a highly conserved putative miR-152-binding site was predicted within the 3′-UTR of DNMT1 mRNA ( Figure 2D and 2E), we generated DNMT1 3′-UTR luciferase reporter containing the miR-152-binding sites (DNMT1 wild-type 3′-UTR) or mutating these sites (DNMT1 Mu 3′-UTR). DNMT1 wildtype 3′-UTR luciferase activity in 293T cells and NSCT2 was reduced by miR-152 transfection, whereas DNMT1 Mu 3′-UTR activity was not affected ( Figure 2F ). Thus, the in silico identified sequence for miR-152 binding in DNMT1 3′-UTR was functionally validated as a bona fide miR-152-binding site. In all, these results suggest that miR-152 directly binds to the DNMT1 3′-UTR and inhibits its expression.
Hypermethylation of miR-152 CpG island promoter causes downregulation of miR-152
To address potential mechanisms accounting for reduced expression of miR-152 in NiS-transformed cells, we first analyzed promoter activity of miR-152 by generating luciferase reporter vector pGL3-miR-152. The results showed that the pGL3-miR-152 luciferase activity increased dramatically compared with pGL3-basal activity in 293T cells ( Figure 3A) . Meanwhile, pGL3-miR-152 luciferase activity in NiS-transformed cells was significantly decreased compared with that in vehicle-treated 16HBE cells ( Figure 3B ), indicating that transcriptional dysfunction was associated with downregulation of miR-152 in NiS-transformed cells. Moreover, treatment with a DNMT inhibitor, DAC, restored miR-152 luciferase activity in NiS-transformed cells ( Figure 3B ), suggesting DNA methylation might be involved in miR-152 expression. Next, we examined the methylation level at 22 CpG sites within CpG island in miR-152 locus by bisulfite-sequencing analysis. The average rate of methylation was 29.5% in NiS-treated cells and 52.3% in NiS-transformed cells, whereas it was only 9.6% in control cells ( Figure 3C ). To further investigate the relationship between DNA hypermethylation in this CpG island and the downregulation of miR-152 expression, we treated NiS-transformed cells with DAC for 5 days. The expression of miR-152 gene was restored to a similar level in 16HBE cells. In addition, treatment with DAC led to decreased cytosine methylation by 77.4% in NiS-transformed cells ( Figure 3C and 3D) . Furthermore, the ChIP assay identified that the bindings of DNMT1 and MeCP2 in miR-152 CpG island promoter were significantly increased in NiS-treated and transformed cells as compared with those in control cells, and that DAC reversed those effects ( Figure 3E ). Taken together, these observations indicate that the hypermethylation at the promoter region of miR-152 plays a causal role in the downregulation of miR-152 expression in NiStransformed 16HBE cells.
Knockdown of DNMT1 increases expression of miR-152 via CpG island promoter hypomethylation
To determine whether upregulation of DNMT1 was directly associated with downregulation of miR-152, we knock-down DNMT1 in NiS-transformed cells, generating stable cell line NSTC2shDNMT1, and detected the expression of miR-152 and CpG island promoter methylation level in NSTC2shDNMT1 and control counterpart. The results showed suppression of DNMT1 led to increased miR-152 expression by 153% and decreased DNA methylation of miR-152 promoter by 82% in NSTC2shDNMT1 cells ( Figure 3C and  3D) . Moreover, the ChIP assay identified the bindings of DNMT1 and MeCP2 in miR-152 CpG island promoter were significantly decreased in NSTC2shDNMT1 cells compared with those in control cells ( Figure 3E ). Together, these data demonstrate that DNMT1 downregulation was sufficient to reverse downregulation of miR-152 via CpG island promoter hypomethylation.
Inhibition of miR-152 increases DNMT1 expression, leading to DNA hypermethylation and increased the DNMT1 and MeCP2 bindings in miR-152 CpG island promoter
To further confirm the reciprocal regulation between miR-152 and DNMT1, we blocked miR-152 expression in 16HBE cells by treatment with single-stranded miR-152 inhibitor and examined endogenous DNMT1 protein expression, as well as DNA methylation level in miR-152 promoter. The results showed that 16HBE cells transfected with anti-miR-152 blocked miR-152 expression ( Figure 4A ) and significantly increased DNMT1 mRNA and protein expression compared with that transfected with the scrambled control ( Figure 4B and 4C). Moreover, bisulfate sequencing and the ChIP assay identified that DNA methylation level, DNMT1 and MeCP2 bindings increased by 116, 123 and 111%, respectively, in miR-152 CpG island promoter in 16HBE cells transfected with anti-miR-152, compared with that in the scrambled control ( Figure 4D-F) . These results indicate miR-152 can decrease DNA methylation in specific loci, probably due to the effect of its inhibition on DNMT1.
miR-152 inhibits cell growth
To determine whether expression of miR-152 contributes to malignant phenotypes involving in NiS-induced cells transformation. We first investigated the effects of ectopic expression of miR-152 on cell growth in NiS-transformed cells by the cell proliferation assay. The results revealed that cells transfected with miR-152 mimic had significantly decreased cell proliferation at 48, 72, and 96 h, compared with control miRNA ( Figure 5A ). To further confirm the ability of miR-152 to inhibit cell growth, we performed colony formation assay at 48 h after transfection and found that the number of colonies formed was reduced in NiS-transformed cells transfected with miR-152, compared with those transfected with a control miRNA ( Figure 5B ). These results suggest that miR-152 inhibits cell growth of NiS-transformed cells. In the converse experiment, when 16HBE cells were transfected with anti-miR-152, the results showed increased proliferation and colonies formation, compared with those in negative control ( Figure 6A and 6B) . Taken together, these data demonstrate miR-152 inhibits cells growth involving in NiS-induced cells transformation.
Discussion
An increasing number of studies support the notion that carcinogeninduced epigenetic changes play key roles during carcinogenesis. Recently, several studies show that epigenetic dysregulation of miRNA expression play important roles in carcinogenesis (11, 12, 24, 25) . In this study, we provide evidence that the downexpression of miR-152 in NiS-transformed cells was regulated by DNMT1 via promoter hypermethylation, and miR-152 was linked to DNA methylation by directly targeting DNMT1 3′-UTR, revealing a crucial functional crosstalk between miR-152 and the DNMT1 via a double-negative feedback loop is involved in NiS-induced malignant transformation. miRNAs belong to a diverse class of highly conserved small RNA molecules that function as critical regulators of gene expression in eukaryotic cells. The biological effects of miRNAs have been widely appreciated, and dysregulations of miRNA have been linked to a variety of human diseases, such as cancers (26, 27) . Several lines of evidences demonstrated epigenetics is responsible for aberrant miRNA expression in several malignancies (28) (29) (30) (31) . miR-152 is located at 17q21.32, and a typical CpG island is around miR-152 promoter. Recently, relatively low expression of miR-152 was shown in gastrointestinal cancer and cholangiocarcinoma (32, 33) . DNA hypermethylation and downregulation of miR-152 were frequently observed in endometrial cancer cell lines and primary tumors (34) . Aberrant DNA methylation of miR-152 CpG islands was reported to correlate with a poor clinical outcome in mixed lineage leukemia (MLL) -rearranged acute lymphoblastic leukemia (35) . So far, few studies reported the relationship between miR-152 and chemical carcinogenesis. In this study, the suppression of miR-152 expression was specifically found in NiS-treated and transformed 16HBE cells and correlated with DNA hypermethylation at the promoter region of miR-152. Treatment with DAC restored the expression of miR-152 in NiS-transformed 16HBE cells. Intriguingly, the ChIP assay showed the proteins associated with DNA methylation writing (DNMT1) and reading (MeCP2) regulated transcriptional activity of miR-152. Moreover, we found double-stranded miR-152 mimics significantly inhibit NiS-transformed cells growth. We further attenuated miR-152 expression in 16HBE cells that expressed higher levels of miR-152 and determined its effect on cell growth. Our results showed that cells transfected with anti-miR-152 showed more growth than those transfected with control anti-miRNA. Taken together, the findings not only further support the tumor-suppressive activity of miR-152 epigenetically silenced in tumor development, but reveal epigenetic silencing of miR-152 is involved in Ni carcinogenesis.
DNA methylation is the most basic epigenetic modification. DNMTs play an important role in mediating aberrant methylation patterns in human cancer cells, which is implicated in tumor development (36) . Increased DNMT expression was demonstrated to be an essential molecular step in cell transformation in vitro (37, 38) , suggesting that abnormalities in DNMT1 expression probably contribute to the development of human cancer. We showed previously that DNMT1 expression was specifically upregulated in NiS-treated and transformed cells. In this study, our findings identified that upregulation of DNMT1 expression results in miR-152 low expression via miR-152 promoter hypermethylation and inhibition of DNMT1 leads to re-expression of miR-152, indicating a malfunctioning of a maintenance DNMT contributes to abnormal miR-152 expression involved in neoplastic transformation.
In this study, we demonstrated that miR-152 represses DNMT1 expression through a direct interaction with a perfectly homologous and highly conserved region of the DNMT1 3′-UTR in NiStransformed cells. These observations are consistent with previous findings that miRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma and endometrial cancer by targeting DNMT1 (22) . More importantly, inhibition of GCACUGA.
GCACUGA. GCACUGA.
GCACUGA. miR-152 expression in 16HBE cells could result in a 30% increase of cell proliferation and increase DNMT1 expression. This in turn led to an increase in DNA methylation, DNMT1 and MeCP2 binding in miR-152 promoter. Collectively, these findings indicate that miR-152 directly interacted with the DNMT1 and the lower levels of miR-152 expression in NiS-transformed cells may be one of the reasons for the abnormal expression of DNMT1, which leads to aberrant DNA methylation, contributing to Ni compound-associated tumorigenicity. Indeed, the complexity of the miRNA-epigenetics relationship is enriched by the recent findings that a subset of miRNAs can regulate the expression levels of effectors of the epigenetic machinery, conversely, epigenetic effectors can also control these miRNAs (39, 40) . Garzon et al. demonstrated in acute myeloid leukemia cells that miR-29b not only directly inhibits both DNMT3a and DNMT3b but also indirectly silences DNMT1 by directly targeting SP1, a transactivator of the DNMT1 gene (23) . In lung cancer, the miR-29 family directly targets DNMT3A and DNMT3B, thereby leading to a reduction of global DNA methylation and the re-expression of DNA hypermethylated and silenced tumor suppressor genes (19) . Moreover, DNMT3b expression is also under the control of miR-148a and miR-148b (41) . On the other hand, several studies showed cancer-specific CpG island hypermethylation in miR-148a, miR-34b/c and miR-9 (42) (43) (44) . In this study, we found high miR-152 was associated with low DNMT1 protein in 16HBE cells, whereas low miR-152 was accompanied with the highest DNMT1 protein expression in NiS-transformed cells. Most importantly, ectopic expression of miR-152 decreased DNMT1 protein expression, depletion of DNMT1 resulted in increased miR-152 expression and vice versa. These results indicate the hypothesis of double-negative feedback regulation between the miR-152 and DNMT1 expression.
Ni-induced epigenetic processes, which include histone modifications and DNA methylation, are highly complex. In recent years, several studies revealed that Ni ions not only directly inhibit the iron and 2-oxoglutaratedependent dioxygenase family of enzymes such as HIF-prolyl hydroxylases, histone demethylase, DNA repair enzymes ABH3 and ABH2, histone methyltransferases, G9a and histone deubiquitinase (6, (45) (46) (47) (48) but also induce phosphorylation of histone H3 at serine 10 by activating c-jun N-terminal kinase-mitogen-activated protein kinase pathway (49 (53) . In this study, our investigation demonstrated that Ni decreased miR-152 expression via promoter hypermethylation. Moreover, we revealed for the first time that a double-negative feedback loop connecting the expression of miR-152, DNMT1 and methylation of the miR-152 promoter existed in NiS-induced cell transformation. Although the sequential occurrence related to upregulation of DNMT1 or downregulation of miR-152 is uncertain in this study, we would like to speculate the phenomena regarding the 'chicken' or the 'egg' paradigm. It has been well documented that Ni exposure leads to generation of ROS. Based on both our study reported here and Soberanes's recent findings that exposure to particulate matter air pollution results in ROS generation and c-jun N-terminal kinase-dependent transcription and expression of DNMT1 (54), we speculate the original NiS exposure firstly induced oxidative stress, resulting in upregulated expression of DNMT1 via ROSc-jun N-terminal kinase-DNMT1 pathway or other unknown mechanism. Once increased expression DNMT1 (egg) occurs in NiS-treated cells, it is recruited to miR-152 CpG island promoter and increases DNA methylation, contributing to decreased miR-152 expression (chicken). On the other hand, downregulated expression of miR-152 further increased DNMT1 expression by less targeting DNMT1 3′-UTR. Thus, a doublenegative feedback loop of miR-152/DNMT1 gradually develops with NiS-induced cell transformation by a self-reinforcing system and could be a driving force for Ni carcinogenesis.
In conclusion, we revealed a crucial functional crosstalk between miR-152 and the DNMT1 via a double-negative feedback loop, which may play an important role in malignant growth of NiS-transformed cells. The discovery of this miRNA-epigenetics regulatory circuit would be highly beneficial for deepening our understanding of Ni carcinogenesis.
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Supplementary Table 1 can be found at http://carcin.oxfordjournals.org/
Funding
National Natural Scientific Foundation of China (grant NSFC30872142 and 81271350 to W.J., NSFC30872178 and 81072366 to J.L., NSFC30900728 to A.X. and NSFC81001259 to W.Z.) The data were expressed as mean ± standard error of the mean (n = 6). *P < 0.05, compared with cells transfected with the negative control.
